Insights

Commercialization Support BioFluidica raised more than $6 million in Series B2 financing to commercialize its liquid biopsy platform and COVID 19 testing device. This creates potential demand for commercialization, manufacturing, regulatory, and go to market services.

Platform Launch The 2022 launch of LiquidScan signals a move from platform development toward market adoption. Sales teams can explore opportunities in laboratory automation, assay integration, distribution, and customer onboarding.

Research Partnerships Collaboration with Wright State University and Premier Health produced published prenatal diagnostic data, while a prenatal blood screening study was announced in 2023. These initiatives may create needs for research tools, clinical study support, and partnership development.

Workflow Technology BioFluidica combines microfluidics, immunoaffinity chemistry, automation hardware, and workflow optimization to enrich multiple biomarkers from one sample. Suppliers of instruments, reagents, software, and lab workflow solutions may find a strong fit.

Growth Potential With 2 to 10 employees and reported revenue of $1 million to $10 million, BioFluidica is a small, funded company operating in a competitive microfluidics market. Scalable outsourced services and solutions that improve throughput or sensitivity may appeal as it grows.

Similar companies to BioFluidica, Inc.

BioFluidica, Inc. Tech Stack

BioFluidica, Inc. uses 8 technology products and services including WordPress, Salesforce, Cloudflare DNS, and more. Explore BioFluidica, Inc.'s tech stack below.

  • Content Management System
  • Customer Relationship Management
  • Cloudflare DNS
    Domain Name Services
  • E-commerce
  • Element UI
    Javascript Frameworks
  • JSON-LD
    Javascript Frameworks
  • WP-PageNavi
    Web Platform Extensions

BioFluidica, Inc.'s Email Address Formats

BioFluidica, Inc. uses at least 4 email formats:
BioFluidica, Inc. Email FormatsExamplePercentage
FLast@biofluidica.comJDoe@biofluidica.com
84%
First.Last@biofluidica.comJohn.Doe@biofluidica.com
10%
First@biofluidica.comJohn@biofluidica.com
3%
FMiddleLast@biofluidica.comJMichaelDoe@biofluidica.com
3%

Frequently Asked Questions

What is BioFluidica, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
BioFluidica, Inc.'s official website is biofluidica.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does BioFluidica, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, BioFluidica, Inc.'s annual revenue is estimated to be $1M - $10M.

What is BioFluidica, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
BioFluidica, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioFluidica, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, BioFluidica, Inc. has approximately 8 employees across 1 continents, including North America. Key team members include Chief Executive Officer: G. S., Chief Operating Officer: J. M. and Cofounder And Chief Technology Officer: S. S. Explore BioFluidica, Inc.'s employee directory with LeadIQ.

What industry does BioFluidica, Inc. belong to?

Minus sign iconPlus sign icon
BioFluidica, Inc. operates in the Biotechnology Research industry.

What technology does BioFluidica, Inc. use?

Minus sign iconPlus sign icon
BioFluidica, Inc.'s tech stack includes WordPress, Salesforce, Cloudflare DNS, Shopify, Microsoft 365, Element UI, JSON-LD and WP-PageNavi.

What is BioFluidica, Inc.'s email format?

Minus sign iconPlus sign icon
BioFluidica, Inc.'s email format typically follows the pattern of FLast@biofluidica.com. Find more BioFluidica, Inc. email formats with LeadIQ.

How much funding has BioFluidica, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, BioFluidica, Inc. has raised $19M in funding. The last funding round occurred on Mar 23, 2022.

When was BioFluidica, Inc. founded?

Minus sign iconPlus sign icon
BioFluidica, Inc. was founded in 2006.
BioFluidica, Inc. logo

BioFluidica, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

BioFluidica, Inc. is a privately held biotechnology company based in San Diego, California, that aims to advance liquid biopsy as a research and clinical tool. Its technology integrates microfluidics, advanced immunoaffinity chemistries, automation hardware, and workflow optimization to improve sensitivity, specificity, and throughput for isolating and enriching multiple disease biomarkers from a single sample. The company has developed the LiquidScan platform for biomarker isolation and has announced related activities, including a prenatal blood screening study in 2023. In 2021 BioFluidica announced a collaboration with Wright State University and Premier Health, with data published in Prenatal Diagnosis. BioFluidica employs a small workforce of between 2 and 10 people and is located at 3377 Carmel Mountain Road, Suite 100, San Diego, CA 92121.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
2-10

Section iconFunding & Financials

  • $19M

    BioFluidica, Inc. has raised a total of $19M of funding over 7 rounds. Their latest funding round was raised on Mar 23, 2022 as a Grant.

  • $1M - $10M

    BioFluidica, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.